Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages
Hims & Hers is launching a weight loss program for its digital health portfolio
Hims launches Hers: Men’s wellness startup now has a “badass sister”